leisure time -WSS

leisure time

author：entertainment 2025-09-06 03:32:40 - browse：81

Stock illustration of computer and medication — Adobe

Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ most significant digital treatments will find a new life as part of PursueCare, which provides online addiction care and mental health counseling.

PursueCare today announced it had raised a $20 million Series B round and that it had acquired Pear’s portfolio of apps that treat people with addiction problems. PursueCare’s CEO Nick Mercadante told STAT the company hopes to develop the market for the treatments where Pear could not, by taking advantage of its access to patients and insurers.

“My view of digital therapeutics is that those point solutions really need a horse to draw the carriage,” he said. “You need a willing and capable service provider that says we’re going to make this a big part of real world care and… then show the health plans how it can save them money in the real world without extra thinking.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： CDC picks Alphabet's Verily for wasterwater surveillance contract

focus

WSS

CRISPR base editing slashes cholesterol levels in monkeys

With Roe v Wade overturned, abortion providers work to adapt

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

The Karikó problem: Lessons for funding basic research

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

IVG is promising — but it won’t replace IVF quite yet

explore

leisure time

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Will an HIV vaccine ever be a reality?

Medical records are filled with copy

A timeline of the missing Titanic tourist submersible

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Stop Congress from blocking public access to science

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

New oral drug delivery patch is modeled after octopus tentacles

Supreme Court strikes down use of affirmative action

Noem? Reynolds? A very early look at the Republican 'veepstakes'

explore

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

3 killed, 8 injured in late

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

The biotech scorecard for Q4: 16 stock

WHO recommends second malaria vaccine

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

explore

focus

knowledge

focus